The global hematopoietic stem cell transplantation market had a market value of US$ 7 billion in 2023 and is expected to reach a market value of US$ 15 billion by 2033, growing at an 8% CAGR from 2023 to 2033. The global hematopoietic stem cell transplantation industry is expected to grow significantly over the forecast period due to the increasing prevalence of leukaemia and lymphoma.

Every year, more than 2000 cord blood hematopoietic stem cell transplants are performed, according to the World Health Organization (WHO) (WHO). Bone marrow and blood contain hematopoietic stem cells (HSCs). Hematopoietic progenitor cells are another name for them (HPCs). Hematopoietic stem cells can produce platelets, white blood cells, and red blood cells, among other blood types. These cells are used to rebuild or replace a patient's hematopoietic system in the treatment of both malignant (such as lymphoma and leukaemia) and non-malignant (such as bone marrow failure and hemoglobinopathies).

Growing healthcare spending, which aids in infrastructure improvement, is another important factor influencing the growth rate of the hematopoietic stem cell transplantation market. Several government organisations intend to improve healthcare infrastructure by increasing funding, which will impact market dynamics. North America leads the hematopoietic stem cell transplantation market due to increased transplant success rates and rising healthcare spending in this area. The presence of significant important players would accelerate the rate of growth in this industry.

Market Competition

Key players in the Hematopoietic Stem Cell Transplantation market are Key players in the hematopoietic stem cell transplantation market are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Sanofi, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio and Talaris Therapeutics.

Get More Details@ https://www.futuremarketinsights.com/reports/hematopoietic-stem-cell-transplantation-market

Key Segments Profiled in the Hematopoietic Stem Cell Transplantation Market Industry Survey

By Transplant Type:

  • Allogeneic
  • Autologous

By Indication:

  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Other Non-Malignant Disorders

By Application:

  • Bone Marrow Transplant
  • Peripheral Blood Stem Cells Transplant
  • Cord Blood Transplant